Time Line

1999

Partnership established between Fiocruz and the Government of the State of Paraná, through the Institute of Technology of Paraná (TECPAR).

2001

Foundation of the Molecular Biology Institute of Paraná (IBMP).

2006

Signing of the Scientific Cooperation Agreement between IBMP, Fiocruz, Hemobrás and Tecpar for the implementation of the NAT in the Brazilian blood donation network, with the objective of preventing transmission of HIV and HCV (hepatitis C) viruses.

2007

Approval of the project of installation of Fiocruz Paraná on the Tecpar campus, within the existing facilities in use by IBMP.

2008

Creation of the INCT Health.

2009

Completion of Plant for Development and Production of Diagnostics Products. Fiocruz Paraná is inaugurated.

2011

IBMP is certified in Good Manufacturing Practices by ANVISA (Brazilian National Agency of Sanitary Surveillance).

IBMP receives a technology demand from the Ministry of Health and commences the Pregnancy care Project, with funding from FINEP.

2012

IBMP receives technology demand from the Ministry of Health and commences the Sepsis Project, with funding from FINEP.

IBMP launches the Microarray Project, with funding from BNDES.

2013

Ministerial Directive no. 2.712, of 12th of November of 2013, determines as compulsory the use of the HIV/HVC NAT Kit in public and private blood centers in Brazil.

2014

IBMP includes the molecular test for detecting HBV (hepatitis B virus) in the NAT Kit.

2015

IBMP launches the Neglected Diseases Project, with funding from BNDES.

2016

The Unified National Health System (SUS) requires a diagnostic kit that provides differential diagnosis of zika, dengue and chikungunya viruses. IBMP begins to produce the amplification modules for diagnosis of each of these diseases.

TOP